RecruitingNCT07338669
Hamburg Acute Renal Injury Study (HARIS)
Hamburg Acute Renal Injury Study
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Enrollment
1,000 participants
Start Date
Sep 16, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The Hamburg Acute Renal Injury Study (HARIS) is a prospective observational cohort study aimed at investigating the mechanisms, risk factors, and clinical determinants of acute kidney injury (AKI) trajectories and consequences.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Hospitalized individuals with acute kidney injury (AKI), defined by the 2012 Kidney Disease: Improving Global Outcomes (KDIGO) criteria or hospitalized individuals with acute illness who have not developed AKI (control group)
- Age ≥ 18 years at time of enrollment
- Personally signed informed consent
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07338669
Related Trials
Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery
NCT0735114913 locations
Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery
NCT070525131 location
QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
NCT0651781015 locations
Improving Patient Assessment After Acute Kidney Injury (AKI)
NCT075695881 location
LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery
NCT058794329 locations